Checkpoint Therapeutics, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Significant Accounting Policies - Net Loss per Share (Details)

v3.25.1

Significant Accounting Policies - Net Loss per Share (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Significant Accounting Policies
Deemed dividends		$ 7.5
Potentially dilutive securities excluded from computation of anti-dilutive shares	44,582,387	32,156,675
May 2023 Registered Direct Offering
Significant Accounting Policies
Shares held in abeyance	1,437,000
October 2023 Registered Direct Offering
Significant Accounting Policies
Shares held in abeyance		1,134,000
Warrants
Significant Accounting Policies
Potentially dilutive securities excluded from computation of anti-dilutive shares	39,567,888	30,097,671
Stock options
Significant Accounting Policies
Potentially dilutive securities excluded from computation of anti-dilutive shares	127,000	127,000
Unvested restricted stock awards
Significant Accounting Policies
Potentially dilutive securities excluded from computation of anti-dilutive shares	4,887,499	1,316,120
Unvested restricted stock units
Significant Accounting Policies
Potentially dilutive securities excluded from computation of anti-dilutive shares	0	615,884

- Definition

Adjustment for deemed dividend for the modification of certain of its existing warrants and issuance of the Common Stock Warrants.

+ References

No definition available.

+ Details

Name:	ckpt_AdjustmentOfDeemedDividendsModificationOfExistingWarrantsAndIssuanceOfCommonStockWarrants
Namespace Prefix:	ckpt_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number of shares of common stock held in abeyance, that is remained unissued as of the reporting date from the warrant exercise.

+ References

No definition available.

+ Details

Name:	ckpt_ClassOfWarrantsOrRightsNumberOfSharesHeldInAbeyance
Namespace Prefix:	ckpt_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=ckpt_May2023RegisteredDirectOfferingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=ckpt_October2023RegisteredDirectOfferingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: